Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Freesmeyer

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 16, 2020
Impact of a Heutagogical, Multimedia-Based Teaching Concept to Promote Self-Determined, Cooperative Student Learning in Clinical RadiologyUlf Teichgräber, Maja Ingwersen, Hans-Joachim Mentzel, et al.
Radiology|March 17, 2026
Transarterial Radioembolization: Medical Staff Dosimetry for <sup>90</sup>Y-Resin, <sup>90</sup>Y-Glass, and <sup>166</sup>Ho-PLLA MicrospheresChristian Kühnel, Tabea Nikola Schmidt, Martin Freesmeyer, et al.
Nuklearmedizin. Nuclear Medicine|January 29, 2026
177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the publicChristian Schütze, Markus Borowski, Martin Freesmeyer, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2022
Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcomaKarin G Schrenk, Wolfram Weschenfelder, Christian Spiegel, et al.
Annals of Hematology|September 8, 2020
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)Hannah Eisfeld, Stefan Kircher, Andreas Rosenwald, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [<sup>68</sup>Ga]Ga-TEoS-DAZAJulia Greiser, Robert Drescher, Mitali Sonawane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2026
From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [<sup>68</sup>Ga]Ga-TEoS-DAZAJulia Greiser, Robert Drescher, Mitali Sonawane, et al.
Cancer Medicine|September 14, 2020
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapyChristine Schmitz, Jan Rekowski, Stefan P Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2020
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV<sub>max</sub> MethodJan Rekowski, Andreas Hüttmann, Christine Schmitz, et al.
Nuklearmedizin. Nuclear Medicine|April 7, 2022
Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in GermanyAndreas Rinscheid, Tilman Janzen, Babak Alikhani, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 16, 2020
Impact of a Heutagogical, Multimedia-Based Teaching Concept to Promote Self-Determined, Cooperative Student Learning in Clinical RadiologyUlf Teichgräber, Maja Ingwersen, Hans-Joachim Mentzel, et al.
Radiology|March 17, 2026
Transarterial Radioembolization: Medical Staff Dosimetry for <sup>90</sup>Y-Resin, <sup>90</sup>Y-Glass, and <sup>166</sup>Ho-PLLA MicrospheresChristian Kühnel, Tabea Nikola Schmidt, Martin Freesmeyer, et al.
Nuklearmedizin. Nuclear Medicine|January 29, 2026
177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the publicChristian Schütze, Markus Borowski, Martin Freesmeyer, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2022
Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcomaKarin G Schrenk, Wolfram Weschenfelder, Christian Spiegel, et al.
Annals of Hematology|September 8, 2020
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)Hannah Eisfeld, Stefan Kircher, Andreas Rosenwald, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [<sup>68</sup>Ga]Ga-TEoS-DAZAJulia Greiser, Robert Drescher, Mitali Sonawane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2026
From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [<sup>68</sup>Ga]Ga-TEoS-DAZAJulia Greiser, Robert Drescher, Mitali Sonawane, et al.
Cancer Medicine|September 14, 2020
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapyChristine Schmitz, Jan Rekowski, Stefan P Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2020
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV<sub>max</sub> MethodJan Rekowski, Andreas Hüttmann, Christine Schmitz, et al.
Nuklearmedizin. Nuclear Medicine|April 7, 2022
Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in GermanyAndreas Rinscheid, Tilman Janzen, Babak Alikhani, et al.
Pageof 21